The effects of ABCA1 on cholesterol efflux and Aβ levels in vitro and in vivo

Journal of Neurochemistry

Volumn 98, Issue 3, 2006, Pages 792-800

  Burns, Mark P ^a   Vardanian, Lilit ^a   Pajoohesh Ganji, Ahdeah ^a   Wang, Lili ^b   Cooper, Matthew ^a   Harris, Donnie C ^a   Duff, Karen ^b   Rebeck, G William ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Alzheimer; Amyloid; ApoE; Oxysterol

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; LIVER X RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WILD TYPE;

AMYLOID BETA-PROTEIN; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHO CELLS; CHOLESTEROL; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; SULFONAMIDES; UP-REGULATION;

EID: 33745880391     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03925.x     Document Type: Article

References (36)

1. Andersson M., Elmberger P. G., Edlund C., Kristensson K. and Dallner G. (1990) Rates of cholesterol, ubiquinone, dolichol and dolichyl-P biosynthesis in rat brain slices. FEBS Lett. 269, 15-18.
2. Bodovitz. S. and Klein W. L. (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440.
3. Burns M., Gaynor K., Olm V., Mercken M., LaFrancois J., Wang L., Mathews P. M., Noble W., Matsuoka Y. and Duff K. (2003) Presenilin redistribution associated with aberrant cholesterol transport enhances {beta}-amyloid production in vivo. J. Neurosci. 23, 5645-5649.
4. Capell A., Steiner H., Willem M., Kaiser H., Meyer C., Walter J., Lammich S., Multhaup G. and Haass C. (2000) Maturation and pro-peptide cleavage of beta-secretase. J. Biol. Chem. 275, 30 849-30 854.
5. Christiansen-Weber T. A., Voland J. R., Wu Y., Ngo K., Roland B. L., Nguyen S., Peterson P. A. and Fung-Leung W. P. (2000) Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am. J. Pathol 157, 1017-1029.
6. Cirrito J. R., Deane R., Fagan A. M., Spinner M. L., Parsadanian M., Finn M. B., Jiang H., Prior J. L., Sagare A., Bales K. R., Paul S. M., Zlokovic B. V., Piwnica-Worms D. and Holtzman D. M. (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J. Clin. Invest 115, 3285-3290.
7. Dietschy J. M. and Turley S. D. (2004) Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375-1397.
8. Fukumoto H., Deng A., Irizarry M. C., Fitzgerald M. L. and Rebeck G. W. (2002) Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels. J. Biol. Chem. 277, 48 508-48 513.
9. Hirsch-Reinshagen V., Maia L. F., Burgess B. L., Blain J. F., Naus K. E., McIsaac S. A., Parkinson P. F., Chan J. Y., Tansley G. H., Hayden M. R., Poirier J., Van Nostrand W. and Wellington C. L. (2005) The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer's disease. J. Biol. Chem. 280, 43 243-43 256.
10. Hirsch-Reinshagen V., Zhou S., Burgess B. L., Bernier L., McIsaac S. A., Chan J. Y., Tansley G. H., Cohn J. S., Hayden M. R. and Wellington C. L. (2004) Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 279, 41 197-41 207.
11. Huse J. T., Pijak D. S., Leslie G. J., Lee V. M. and Doms R. W. (2000) Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J. Biol. Chem. 275, 33 729-33 737.
12. Hutter-Paier B., Huttunen H. J., Puglielli L., Eckman C. B., Kim D. Y., Hofmeister A., Moir R. D., DomnitZ. S. B., Frosch M. P., Windisch M. and Kovacs D. M. (2004) The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44, 227-238.
13. Jick H., Zornberg G. L., Jick S. S., Seshadri S. and Drachman D. A. (2000) Statins and the risk of dementia. Lancet 356, 1627-1631.
14. Jin L. W., Shie F. S., Maezawa I., Vincent I. and Bird T. (2004) Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am. J. Pathol 164, 975-985.
15. Klein I., Sarkadi B. and Varadi A. (1999) An inventory of the human ABC proteins. Biochim. Biophys. Acta 1461, 237-262.
16. Koldamova R. P., Lefterov I. M., Staufenbiel M., Wolfe D., Huang S., Glorioso J. C., Walter M., Roth M. G. and Lazo J. S. (2005b) The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 280, 4079-4088.
17. Koldamova R., Staufenbiel M. and Lefterov I. (2005a) Lack of ABCA1 considerably decreases brain Apoe level and increases amyloid deposition in APP23 mice. J. Biol. Chem. 280, 43 224-43 235.
18. Lam F. C., Liu R., Lu P., Shapiro A. B., Renoir J. M., Sharom F. J. and Reiner P. B. (2001) beta-Amyloid efflux mediated by p-glycoprotein. J. Neurochem. 76, 1121-1128.
19. Lee S. J., Liyanage U., Bickel P. E., Xia W., Lansbury P. T. Jr and Kosik K. S. (1998) A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med. 4, 730-734.
20. Lund E. G., Xie C., Kotti T., Turley S. D., Dietschy J. M. and Russell D. W. (2003) Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278, 22980-22988.
21. Oram J. F. and Heinecke J. W. (2005) ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85, 1343-1372.
22. Puglielli L., Konopka G., Pack-Chung E., Ingano L. A., Berezovska O., Hyman B. T., Chang T. Y., Tanzi R. E. and Kovacs D. M. (2001) Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol. 3, 905-912.
23. Rockwood K., Kirkland S., Hogan D. B., MacKnight C., Merry H., Verreault R., Wolfson C. and McDowell I. (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch. Neurol. 59, 223-227.
24. Runz. H., Rietdorf J., Tomic I., de Bernard M., Beyreuther K., Pepperkok R. and Hartmann T. (2002) Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J. Neurosci. 22, 1679-1689.
25. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G. and Simons K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. U S A 95, 6460-6464.
26. Sun Y., Yao J., Kim T. W. and Tall A. R. (2003) Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J. Biol. Chem. 278, 27688-27694.
27. Tachikawa M., Watanabe M., Hori S., Fukaya M., Ohtsuki S., Asashima T. and Terasaki T. (2005) Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J. Neurochem. 95, 294-304.
28. Urano Y., Hayashi I., Isoo N., Reid P. C., Shibasaki Y., Noguchi N., Tomita T., Iwatsubo T., Hamakubo T. and Kodama T. (2005) Association of active gamma-secretase complex with lipid rafts. J. Lipid Res. 46, 904-912.
29. Wahrle S., Das P., Nyborg A. C., McLendon C., Shoji M., Kawarabayashi T., Younkin L. H., Younkin S. G. and Golde T. E. (2002) Cholesterol-Dependent [gamma]-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains. Neurobiol. Dis 9, 11-23.
30. Wahrle S. E., Jiang H., Parsadanian M., Hartman R. E., Bales K. R., Paul S. M. and Holtzman D. M. (2005) Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 280, 43 236-43 242.
31. Wahrle S. E., Jiang H., Parsadanian M., Legleiter J., Han X., Fryer J. D., Kowalewski T. and Holtzman D. M. (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279, 40 987-40 993.
32. Wang N., Lan D., Chen W., Matsuura F. and Tall A. R. (2004) ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl Acad. Sci. U S A 101, 9774-9779.
33. Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T. and Selkoe D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513-517.
34. Wolozin B., Kellman W., Ruosseau P., Celesia G. G. and Siegel G. (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57, 1439-1443.
35. Xie C., Lund E. G., Turley S. D., Russell D. W. and Dietschy J. M. (2003) Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res. 44, 1780-1789.
36. Yamazaki T., Chang T. Y., Haass C. and Ihara Y. (2001) Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J. Biol. Chem. 276, 4454-4460.